Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide (Ozempic) and tirzepatide (Mounjaro) are both FDA-approved medications that help reduce appetite and support weight loss, but they work through different pathways in your body. Clinical trials show tirzepatide produces greater average weight reduction than semaglutide, with some patients losing up to 22% of their body weight over 68 weeks. Choosing between them depends on your individual response, lifestyle, and genetic predispositions.

How Ozempic and Mounjaro Work Differently in Your Body

Ozempic (semaglutide) activates one receptor in your brain and gut called GLP-1R. This receptor signal tells your body to slow digestion, reduce hunger signals, and feel full longer after eating. The medication works by mimicking a natural hormone your pancreas produces to manage blood sugar and appetite.

Mounjaro (tirzepatide) activates two separate receptors: GLP-1R and GIPR (glucose-dependent insulinotropic polypeptide receptor). By engaging both pathways simultaneously, tirzepatide creates a dual-action effect that may produce stronger appetite suppression and better metabolic control. This dual-receptor design is why tirzepatide users often report more significant weight loss results in clinical studies.

Clinical Weight Loss Results: Ozempic vs Mounjaro Head-to-Head

In the SUSTAIN trial series, semaglutide patients achieved average weight losses ranging from 10% to 17% of body weight depending on the dose and study duration. At the highest approved dose, semaglutide showed consistent efficacy for many patients, though individual responses vary widely based on genetics and lifestyle factors.

The SURMOUNT trials for tirzepatide demonstrated average weight reductions of 16% to 22% across different dose levels over 68 weeks. When tirzepatide and semaglutide were compared in real-world settings, patients on tirzepatide frequently achieved greater reductions in appetite and body weight, particularly in the first 12 to 16 weeks of therapy. However, not every patient responds better to tirzepatide—genetics, gut health, and adherence all influence outcomes.

Side Effects and Tolerability: What You Should Expect

Both medications commonly cause mild gastrointestinal side effects in the first 2 to 4 weeks, including nausea, constipation, or diarrhea. These effects usually decrease over time as your body adjusts. Serious side effects are rare but may include pancreatitis or severe dehydration if you don't maintain adequate fluid intake.

Tirzepatide may cause slightly stronger initial nausea in some patients because it engages two receptor pathways instead of one, though this does not mean it is less safe. Both drugs require gradual dose escalation over weeks to months to minimize side effects. Your PlexusDx provider can adjust your dose schedule based on your tolerance and response.

Genetic Testing to Predict Your Best Weight Loss Response

Your genes influence how strongly you respond to GLP-1 therapy and whether dual-receptor medications may work better for you than single-receptor drugs. PlexusDx offers the Precision Peptide Genetic Test, which analyzes key variants in your GLP1R, GIPR, FTO, and MC4R genes to map your individual peptide response across 14 metabolic pathways.

If your genetic profile shows stronger GIPR pathway activation potential, a dual-compound therapy like tirzepatide or PlexusDx's GLP-Squared Injection may deliver better appetite control. Conversely, some patients with certain genetic variants respond equally well to semaglutide alone and prefer its simplicity. The Precision Peptide test costs $99 as an add-on after your first month of treatment and helps eliminate guesswork from your weight loss plan.

Cost and Access: Compounded Tirzepatide Through PlexusDx

PlexusDx supplies compounded semaglutide and tirzepatide injections from licensed 503A compounding pharmacies to all 50 states without requiring insurance or a membership fee. Compounded tirzepatide injection starts at $249 per month across our commitment tiers, and your dose may need to go up—your price won't. Oral tirzepatide is available at $279 per month if you prefer tablets.

Both medications are HSA and FSA eligible, making them accessible to more patients than brand-name options. PlexusDx handles prescriptions, pharmacy coordination, and delivery, so you spend less time managing logistics and more time focusing on your weight loss goals. Your first consultation and dosing plan are included in your monthly rate, with no hidden per-dose charges or surprise increases.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will tirzepatide make me lose more weight than semaglutide?

Clinical trials show tirzepatide produces greater average weight loss (16–22%) compared to semaglutide (10–17%), but individual results vary. Your genetics, diet, exercise, and body composition determine your actual outcome. PlexusDx's Precision Peptide Genetic Test can help identify which medication pathway your body responds to most strongly.

How long does it take to see weight loss results?

Most patients notice reduced appetite within 3 to 7 days of starting therapy, with visible weight loss appearing by weeks 4 to 8. Average weight loss accelerates between weeks 8 and 16 as your dose is optimized. Full therapeutic benefit typically emerges after 12 to 16 weeks of consistent use.

Can I switch from Ozempic to Mounjaro if I'm not satisfied?

Yes, many patients transition between semaglutide and tirzepatide with medical oversight. PlexusDx providers can modify your prescription during your next monthly check-in. Some patients alternate or combine therapies based on their genetic profile and response patterns.

Is compounded tirzepatide as safe as brand-name Mounjaro?

Compounded tirzepatide from licensed 503A pharmacies meets the same pharmaceutical quality and sterility standards as brand medications. All PlexusDx compounds are manufactured under strict FDA oversight and quality protocols. The active ingredient is chemically identical; the only difference is the source and cost.

What does the Precision Peptide Genetic Test tell me?

The test analyzes your GLP1R, GIPR, FTO, and MC4R gene variants across 14 metabolic pathways to predict which peptide therapy and dose range will work best for your body. Results inform whether you'll respond better to single-receptor (semaglutide) or dual-receptor (tirzepatide) medications, helping PlexusDx personalize your treatment from month one.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves